Contribution of selected vitamins and trace elements to immune function
/in International Publications, MicronutrientsDendritic cells reconstituted with a human heparanase gene induce potent cytotoxic T-cell responses against gastric tumor cells in vitro
/in Gastric Cancer, International PublicationsLevels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects
/in HIV/AIDS, International PublicationsLocalized hyperthermia combined with intratumoral dendritic cells induces systemic antitumor immunity
/in Dendritic Cells, Hyperthermia, International Publications, Prostate CancerWeekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area
/in Cervical Cancer, International PublicationsRobust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral Ag
/in HIV/AIDS, International PublicationsImmunity of unloaded dendritic cells in lung melanoma of mice
/in International Publications, Malignant MelanomaReview: dendritic cell-based vaccine in the treatment of patients with advanced melanoma
/in International Publications, Malignant MelanomaA combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model
/in Breast Cancer, Dendritic Cells, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer